Odyssey Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $15.10-$28 |
Market Cap | $1.2B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $99,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$120.6M |
Diluted EPS | -$3.26 |
News
See moreYahoo Finance • 2 months ago
Kardigan rises in Nasdaq debut after upsized $400 million IPO
Yahoo Finance • 2 months ago
Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance • 3 months ago
Catalyst Watch: FedEx splits, tech CEOs hit Computex, Quantinuum IPO, and the jobs report
About
CEO | Dr. Gary D. Glick Ph.D. |
Address | 51 Sleeper Street, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 100 |